We have found 9 results when searching "Naloxone"
East Region Formulary Prepared by C Satti/S McNeill March-April 2025 Checked by M Ross Summary of updates to East Region Formulary (ERF) website. The purpose of this summary is to detail the main ...
Prepared May 2021 DM/ZH Summary of Lothian Joint Formulary Amendments The purpose of this summary is to detail the main changes to the LJF sections and provide additional information on the reasons f...
Prepared September 2020 DM Summary of Lothian Joint Formulary Amendments The purpose of this summary is to detail the main changes to the LJF sections and provide additional information on the reaso...
East Region Formulary ERFC Minutes 30 November 2022 Page 1 of 21 East Region Formulary Committee Minutes Date: 30 November 2022 Time: 2pm – 4pm Location: MS Teams Present: Alison Casey Senio...
East Region Formulary ERFC Minutes 05 February 2025 Page 1 of 14 East Region Formulary Committee Minutes Date: 05 February 2025 Time: 2.00pm – 4:30pm Location: MS Teams Present: Carla Capaldi ...
East Region Formulary ERFC Minutes 13 May 2026 Page 1 of 15 East Region Formulary Committee Minutes Date: 13 May 2026 Time: 2.00pm – 4:20pm Location: MS Teams Present: Mona Boriceanu Advanced N...
SMC2123 : Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. The intention of the naloxone component is to deter intravenous misuse. ...
355/07 : For restricted use within NHS Scotland for substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. Buprenorphine/naloxone is rest...
541/09 : Severe pain which can be adequately managed only with opioid analgesics. Naloxone is added to counteract opioid-induced constipation.
